The homozygous CD46 gene edit reduced in vitro BVDV susceptibility to a level comparable to that observed in cells with a complete CD46 gene deletion (CD46Δ), demonstrating that the CD46 A82LPTFS substitution eliminates the virus’ ability to use CD46 to initiate infection. The gene discussed is CD46; the disease is infection.